Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
2019 · The Lancet Neurology · 135 citations
https://doi.org/10.1016/s1474-4422(19)30319-9